Neogen Corporation (NEOG): Price and Financial Metrics

Neogen Corporation (NEOG): $43.18

-0.38 (-0.87%)

POWR Rating

Component Grades














  • NEOG scores best on the Stability dimension, with a Stability rank ahead of 94.78% of US stocks.
  • NEOG's strongest trending metric is Stability; it's been moving up over the last 31 weeks.
  • NEOG's current lowest rank is in the Sentiment metric (where it is better than 29.39% of US stocks).

NEOG Stock Summary

  • With a one year PEG ratio of 944.84, Neogen Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.52% of US stocks.
  • For NEOG, its debt to operating expenses ratio is greater than that reported by just 0.53% of US equities we're observing.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.09 for Neogen Corp; that's greater than it is for just 8.33% of US stocks.
  • Stocks that are quantitatively similar to NEOG, based on their financial statements, market capitalization, and price volatility, are HCCI, CVCO, RBC, IPAR, and ICFI.
  • NEOG's SEC filings can be seen here. And to visit Neogen Corp's official web site, go to

NEOG Valuation Summary

  • NEOG's price/sales ratio is 10.3; this is 13.08% lower than that of the median Healthcare stock.
  • NEOG's price/earnings ratio has moved up 48.7 over the prior 243 months.
  • Over the past 243 months, NEOG's price/sales ratio has gone up 7.2.

Below are key valuation metrics over time for NEOG.

Stock Date P/S P/B P/E EV/EBIT
NEOG 2017-09-15 7.7 5.9 63.8 40.8
NEOG 2015-09-30 5.8 4.6 49.5 31.0
NEOG 2013-07-25 6.9 5.6 52.6 33.7
NEOG 2012-12-20 5.9 4.9 47.8 30.4
NEOG 2009-10-09 3.7 3.4 31.1 18.9
NEOG 2008-10-02 3.8 3.5 32.4 20.4

NEOG Growth Metrics

  • Its 4 year revenue growth rate is now at 35.2%.
  • Its 2 year price growth rate is now at -4.46%.
  • Its 2 year cash and equivalents growth rate is now at -38.13%.
NEOG's revenue has moved up $159,773,000 over the prior 67 months.

The table below shows NEOG's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 450.108 84.748 61.469
2020-12-31 433.268 92.93 60.292
2020-09-30 426.071 87.293 60.683
2020-06-30 418.17 85.878 59.475
2020-03-31 418.858 81.127 58.943
2019-12-31 416.689 71.731 59.816

NEOG Price Target

For more insight on analysts targets of NEOG, see our NEOG price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $43.75 Average Broker Recommendation 1.67 (Moderate Buy)

NEOG Stock Price Chart Interactive Chart >

Price chart for NEOG

NEOG Price/Volume Stats

Current price $43.18 52-week high $48.85
Prev. close $43.56 52-week low $33.11
Day low $43.10 Volume 218,586
Day high $43.93 Avg. volume 375,227
50-day MA $45.15 Dividend yield N/A
200-day MA $42.35 Market Cap 4.62B

Neogen Corporation (NEOG) Company Bio

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The company was founded in 1981 and is based in Lansing, Michigan.

NEOG Latest News Stream

Event/Time News Detail
Loading, please wait...

NEOG Latest Social Stream

Loading social stream, please wait...

View Full NEOG Social Stream

Latest NEOG News From Around the Web

Below are the latest news stories about Neogen Corp that investors may wish to consider to help them evaluate NEOG as an investment opportunity.

Companion Animal Diagnostics Market Revenue 2021: Top 3 Trends Driving the Industry Expansion Through 2027; Global Market Insights Inc.

Major companion animal diagnostics market players include IDEXX Laboratories, Abaxis, Heska Corporation, Neogen, Zoetis, Thermo Fischer Scientific and Randox. Major companion animal diagnostics market players include IDEXX Laboratories, Abaxis, Heska Corporation, Neogen, Zoetis, Thermo Fischer Scientific and Randox.

Intrado Digital Media | July 29, 2021

NEOGEN Launches Reveal® Q+ for Δ9-THC in Hemp

NEOGEN Corporation (NASDAQ: NEOG) announced today that they have launched a test that can quickly and accurately detect levels of the delta-9-tetrahydrocannabinol (Δ9-THC) cannabinoid in hemp plants.

Yahoo | July 28, 2021

Animal Disinfectant Market - Neogen Corporation, GEA Group AG, Lanxess AG, Zoetis Inc., Kersia Group, CID Lines, Albert Kerbl GmbH, PCC Group, Laboratoires Ceetel- CMPC, G SheperdAnimal Health, Sanosil AG, DeLaval Inc., Diversey Holdings Ltd.

According to the Center for Disease Control and Prevention (CDC): 2019 report, the U.S. government released the list of top zoonotic diseases that can be transmitted between animals and people. The list includes zoonotic influenza, salmonellosis, west Nile virus, plague,

OpenPR | July 26, 2021

Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Yahoo | July 26, 2021

Animal Health Diagnostics Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: IDEXX Laboratories (US), Abaxis (US), Thermo Fisher Scientific (US), Neogen (US),

The documented report on Global Animal Health Diagnostics Market by Reports Globe aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment and better decision making on whether or []

Jumbo News | July 25, 2021

Read More 'NEOG' Stories Here

NEOG Price Returns

1-mo -6.33%
3-mo -9.11%
6-mo 6.76%
1-year 12.49%
3-year 5.95%
5-year 108.33%
YTD 8.90%
2020 21.51%
2019 14.49%
2018 -7.55%
2017 24.56%
2016 16.77%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9397 seconds.